Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons. [electronic resource]
Producer: 20171219Description: 1607-15 p. digitalISSN:- 1473-5571
- Adolescent
- Adult
- Americas
- Antitubercular Agents -- administration & dosage
- Asia
- Child
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- HIV Infections -- complications
- Humans
- Isoniazid -- administration & dosage
- Male
- Prospective Studies
- Rifampin -- administration & dosage
- Treatment Outcome
- Tuberculosis -- complications
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.